SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alliance Pharmaceutical
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miguel M. de la O who wrote (312)10/24/1998 1:34:00 AM
From: Alok Sinha  Read Replies (1) of 548
 
I doubt any deal with Oxygent is in the works. The move and volume in the stock may be related to some announcement forthcoming regarding beginning of Phase III trials for Oxygent and pivtal study (phase II/III) for Liquivent. Aliance's intent was to begin these studies before the end of the year afer finalizing the protocol with the FDA.

Regards

Alok
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News